AChR自身抗体的致病性质是异质分布的,并且在患有肌痛性质严重症的患者中经历时间变化
Fatemeh Khani-Habibabadi1,2, Bhaskar Roy1, Minh C Pham2
1Department of Neurology, Yale School of Medicine, New Haven, CT.
Neurology(R) neuroimmunology & neuroinflammation
|July 18, 2025
概括
这项研究揭示了肌痛性骨髓灰质炎 (MG) 患者的多种类型的乙胆受体 (AChR) 自身抗体配置文件,包括各种致病机制和同型. 综合性自身抗体分析对于了解MG治疗结果至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 乙胆受体 (AChR) 自抗体通过补充激活,受体内化和ACH结合部位阻断驱动肌痛性骨髓灰质炎 (MG) 发病.
- 目前的疗法通过抑制补体或阻断新生儿Fc受体 (FcRn) 来向这些自身抗体,但在解决所有致病机制或抗体类型方面存在局限性.
研究的目的:
- 在一般性MG患者中研究ACHR自身抗体致病机制,同型和IgG亚类的异质性.
- 了解这些自身抗体特征如何在纵向上变化,并可能与疾病严重程度相关.
主要方法:
- 利用基于活细胞的先进测定方法,在两年内分析了50名通用MG患者的血清样本.
- 评估了补体激活,ACHR内部化,ACH结合部位阻断以及IgA,IgM和IgG子类 (IgG1,IgG2,IgG3) 的存在.
主要成果:
- 很大一部分患者与IgG同时出现IgA和IgM自身抗体.
- 补充激活和ACHR内化是最常见的致病机制,通常同时发生.
- 自动抗体结合能力与补体激活和ACHR内化相关;观察到时间波动.
结论:
- 鉴定出独特的MG患者亚群,其特点是具有特定的自身抗体配置文件和致病机制,目前的治疗方法可能无法完全解决这些问题.
- 建议在临床试验中进行全面的自身抗体分析,以探索MG治疗反应与治疗反应的关联.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
01:15Myasthenia Gravis: Diagnostic Tests
1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
01:26Chemical Synapses
9.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.1K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
820
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
820